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Using hyperpolarised NMR and DFT to rationalise the unexpected 
hydrogenation of quinazoline to 3,4-dihydroquinazoline  
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Dearb, A. Jonathon Holmesa, Richard O. Johna, Ryan E. Mewisa, Natalie Pridmorea, Andy D. 
Robertsb and Adrian C. Whitwooda and Simon B. Ducketta*
PHIP and SABRE hyperpolarized NMR methods are used to follow 
the unexpected metal-catalysed hydrogenation of quinazoline 
(Qu) to 3,4–dihydroquinazoline as the sole product. A solution of 
[IrCl(IMes)(COD)] in dichloromethane reacts with H2 and Qu to 
form [IrCl(H)2(IMes)(Qu)2] (2). The addition of methanol then 
results in its conversion to [Ir(H)2(IMes)(Qu)3]Cl (3) which catalyses 
the hydrogenation reaction. Density functional theory calculations 
are used to rationalise a proposed outer sphere mechanism in 
which (3) converts to [IrCl(H)2(H2)(IMes)(Qu)2]Cl (4) and neutral 
[Ir(H)3(IMes)(Qu)2] (6) both of which are involved in the formation 
of 3,4–dihydroquinazoline via the stepwise transfer of H+ and H-, 
with H2 identified as the reductant. Successive ligand exchange in 
3 results in the production of thermodynamically stable 
[Ir(H)2(IMes)(3,4-dihydroquinazoline)3]Cl (5).  
The development and refinement of hyperpolarization 
methods over the past 20 years has enhanced the power of 
nuclear magnetic resonance (NMR) as a spectroscopic tool 
while leading to clinical magnetic resonance imaging (MRI) 
applications.1-4 The most well-established of these techniques, 
Dynamic Nuclear Polarization (DNP), has been used in areas as 
diverse as materials characterisation,5, 6 mechanistic and 
kinetic studies of chemical and enzymatic transformations by 
stopped flow DNP–NMR,7-9 and the in vivo 1H, 13C and 15N 
monitoring of metabolism.10-12 Other approaches have 
exploited para-hydrogen (p–H2) as an agent to transfer 
polarization. Para-Hydrogen Induced Polarization (PHIP)13 was 
pioneered by Weitekamp,14, 15 Bargon16 and Eisenberg,13, 17 and 
normally requires an unsaturated molecule to act as a 
hydrogen acceptor. Reaction products formed by integrating 
protons from the p–H2 are created with non-equilibrium 
nuclear spin distributions and as a result yield greatly 
enhanced NMR signals.18 This approach has been used widely 
to investigate the reactivity of metal hydride complexes and 
probe their role in, for example, metal catalysed 
hydrogenation19-21 and hydroformylation22-24 reactions. Other 
applications of PHIP have seen p–H2 used to sensitize MRI 
studies,25-28 to probe heterogeneous reactions29-31 and 
metabolism32 and more recently to create long-lived magnetic 
states.33-35  
 The requirement for chemical modification in PHIP has 
been addressed through the Signal Amplification By Reversible 
Exchange (SABRE) hyperpolarization method which, rather 
than relying on the hydrogenation of an unsaturated 
substrate, instead uses a metal complex as a chemical 
intermediary to bring the sample into temporary contact with 
p-H2.36, 37, 38 This method has been shown to polarize a wide 
range of substrates, leading to very large MR signal 
enhancements39 in the liberated substrate. Theoretical 
treatments have rationalized this process in terms of the J–
coupling interactions that exist in these labile complexes40, 41 
whilst subsequent developments have led the the production 
of hyperpolarised long-lived singlet states using SABRE.42, 43   
 In this paper both PHIP and SABRE are used to follow the 
unexpected metal-catalysed hydrogenation of quinazoline (Qu) 
to 3,4–dihydroquinazoline. Density Functional Theory (DFT) is 
combined with the experimental observations to rationalise a 
proposed outer sphere mechanism for the reaction.  The 
experimental process starts with the reaction of a  
dichloromethane-d2 solution of [IrCl(COD)(IMes)], 1,44 (IMes = 
1,3–bis(2,4,6–trimethylphenyl)imidazole–2–ylidene and COD = 
cyclooctadiene) with Qu and H2. Rather than yielding the Qu 
analogue of [Ir(H)2(IMes)(Qu)3]Cl which forms from the 
analogous reaction with quinoline,45 neutral 
[IrCl(H)2(IMes)(Qu)2] (2) forms according to Scheme 1. The 1H 
NMR spectrum of 2 at 298 K yields two inequivalent hydride 
ligand signals at d −22.84 (Ha, linewidth 16.7 Hz) and d −23.79 
(Hb, linewidth 16.3 Hz). When p–H2 is employed as the 
reactant at 253 K these two hydride resonances exhibit weak 
PHIP enhancement37 which confirms their assignment as a pair 
of cis hydride ligands. In addition, the proton resonances 
attributable to the Qu ligand trans to the hydrides as well as 
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those of free Qu show weak SABRE enhancement thus 
confirming the transient binding of the Qu ligand to the metal 
centre.  
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Scheme 1 Solvent dependent reaction of 1 with quinazoline and H2 leads to 2 in 
dichloromethane and unstable 3 in methanol-d4. 
 When this process is repeated at 298 K, the two hydride 
ligands of 2 no longer exhibit PHIP, but all six of the free Qu 
aromatic proton resonances exhibit SABRE, with the degree of 
1H signal enhancement ranging from 61–fold for H8 to 108–
fold for H2. An average enhancement of 85–fold over all six 
protons of Qu was achieved for a concentration of 1 of 5 mM 
with a 17–fold ligand excess (Fig. 1). Full characterisation and 
details confirming the assignment of 2 to [IrCl(H)2(IMes)(Qu)2] 
are given the ESI. 
 
Fig. 1 Typical 1H NMR spectra of the aromatic region of a sample consisting of Qu 
(0.1 M) and 1 (5 mM) in dichloromethane-d2: (A) magnetisation at thermal 
equilibrium and (B) hyperpolarised magnetisation created by SABRE at 65 G.  
 The fluxional behaviour of 2 in dichloromethane–d2 was 
then probed by EXSY methods over the temperature range 263 
to 299 K. Its inequivalent hydrides, Ha and Hb, were found to 
interchange positions, with H2 elimination and dissociative Qu 
loss also being detected. The H2 loss pathway shows a [H2] 
dependence which is consistent with the involvement of the 
intermediate [IrCl(H)2(η2-H2)(IMes)(Qu)] (4), a product that 
forms when the ligand-dissociation-product 
[IrCl(H)2(IMes)(Qu)] is trapped by H2 rather than Qu. This 
mechanism is consistent with the reported H2 exchange 
pathway of IrCl(H)2(η2-H2)(PPri3)2.47, 48 The associated rate data 
from these studies yielded values for DH‡ and DS‡ of 87.8 ± 1 kJ 
mol-1 and 75 ± 3 J K-1 mol-1, respectively, for Quequatorial loss in 
accordance with a dissociative first step and a relatively high 
Ir-N bond energy.46   
 DFT calculations were performed to corroborate the 
assignment of 2. With dichloromethane solvation included at 
the PCM continuum level, the calculations showed dispersion-
corrected 2 to be 38.5 kJ mol-1 more stable than 
[Ir(H)2(IMes)(Qu)3]Cl (3) at 298 K, consistent with the 
observation of 2 as the only reaction product in 
dichloromethane. With methanol solvation however, 2 is 
predicted to be just 8.8 kJ mol-1 more stable than 3 in 
agreement with the expectation that charge-stabilizing 
methanol increases the likelihood of formation of 3. 
 Prompted by this result, a further experiment was 
conducted in which a dichloromethane-d2 solution of 1 
containing a 20–fold excess of Qu and 50 ml of methanol-d4 
was placed under p-H2. As anticipated, 1H NMR signals due to 3 
now dominate with the six free Qu resonances showing 
substantial SABRE signal gains. However, over the course of 
the next few hours, the SABRE-enhanced NMR spectra showed 
dramatic changes that signalled the exclusive conversion of Qu 
into 3,4–dihydroquinazoline,49-51 with no evidence for the 
formation of the corresponding 1,2–dihydroquinazoline52 
isomer (see ESI for further details of the characterisation).   
 When the reaction was repeated in neat methanol-d4 (Fig. 
2), the SABRE 1H-NMR spectra initially show dominant 
hyperpolarized signals for Qu but with minor signals due to 
3,4-dihydroquinazoline present from the start. This suggests 
that the conversion of Qu to 3,4-dihydroquinazoline proceeds 
rapidly under these conditions. While all seven ring protons of 
3,4-dihydroquinazoline show SABRE, no visible signal 
enhancement is seen for its exchangeable NH proton. In 
addition to these changes in the aromatic region, a single 
hydride signal emerges from a complex array of peaks at d 
−23.6. This signal is associated with the 3,4–
dihydroquinazoline analogue of 3, [Ir(H)2(IMes)(3,4–
dihydroquinazoline)3]Cl (5), as characterised by NMR and and 
whose relatively greater stability than 3 was validated by DFT 
(3 kJ mol-1). This complex hydride resonance behaviour reflects 
the formation of metal complex products that feature varying 
proportions of 3,4-dihydroquinazoline and quinazoline ligands 
with 5 the most stable of these and ultimately dominating the 
spectrum. At the completion of the reaction, 5 delivers 
hyperpolarised signals for 3,4–dihydroquinazoline at d 7.1, 
6.96, 6.88, 6.68 and 4.56 that exhibit enhancements factors of 
96–, 40–, 40–, 35– and 26–fold respectively. Their average 
enhancements are lower than those of quinazoline which is 
consistent with the DFT prediction that 5 is more stable than 3. 
 A series of control reactions were then used to probe this 
process in more detail. In the first, the original 
dichloromethane-d2 solution of 2 and Qu was heated under a 
H2 atmosphere overnight at 323 K in the absence of methanol. 
No evidence for the hydrogenation of Qu was observed and 
hence 2 cannot be involved in this process. A direct inner 
sphere mechanism involving the stepwise insertion of 
quinazoline into the Ir–H bonds of 3 might be predicted but 
our DFT calculations suggest that this process has an inhibiting 
energy barrier of >175 kJ mol-1. A second possibility involving 
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transfer hydrogenation53-56 that works well with related 
substrates57 would involve methanol as the proton source.58 In 
order to identify the reductant, we placed a solution of 3 in 
pure methanol under H2 and observed gradual conversion of 
quinazoline to 3,4–dihydroquinazoline. Replacing the H2 
atmosphere with N2 stopped the hydrogenation completely 
with no further increases observed in the 3,4–
dihydroquinazoline 1H NMR signal over the following 24 hr 
period. Subsequent addition of ammonium formate, a known 
proton source for transfer hydrogenation ,59-61 failed to initiate 
any further hydrogenation, even at 323 K, and so, on this basis, 
we conclude that the reductant must be H2.  
 
Fig. 2 Plot of a series of expansions of the aromatic region of five 1H NMR spectra 
that track the conversion of quinazoline into 3,4–dihydroquinazoline in methanol 
over a 24 hr period.  
 We note that hydrogenation of 2–methylquinoline has 
been reported to take place via an outer sphere mechanism 
involving an iridium dihydrogen dihydride complex.62,63 Such a 
mechanism is consistent with our SABRE results and the 
dispersion-corrected DFT calculations used here to underpin 
Scheme 2 (see ESI). Thus, we propose a mechanism by which 3 
first forms [Ir(H)2(H2)(IMes)(Qu)2]Cl (4) (33 kJ mol-1 higher in 
energy than 3 as determined by the DFT calculations), before 
conversion to neutral [Ir(H)3(IMes)(Qu)2] (6) and protonated 
quinazoline (64.7 kJ mol-1 higher in energy) via reaction 
intermediate [Ir(H)2(IMes)(Qu)2…H…H…Qu]Cl. Hydride ligand 
transfer then follows to form 3,4–dihydroquinazoline (overall 
reaction exothermic by -33.7 kJ mol-1 at 298 K). As the catalytic 
cycle continues, successive ligand exchange in 3 results 
eventually in the thermodynamically stable metal complex 
product, 5. The importance of the choice of methanol as 
solvent in realising the hydrogenation reaction lies in its role in 
stabilising 3 as a product of the reaction of 1 with Qu and H2 
rather than acting as a proton source for the transfer 
hydrogenation step. 
 In summary, we have shown that 1H NMR spectroscopy 
combined with SABRE can be used to follow the metal-
catalysed hydrogenation of quinazoline exclusively to 3,4–
dihydroquinazoline. While [IrCl(H)2(IMes)(Qu)2] (2) is unable to 
catalyse this transformation, the reaction proceeds readily via 
[IrCl(H)2(IMes)(Qu)3]Cl (3) with [Ir(H)2(IMes)(3,4–
dihydroquinazoline)3]Cl (5) the thermodynamically favoured 
metal complex product. The reductant in this process is H2, 
and a solvent-dependent outer–sphere mechanism is 
proposed which requires the formation of 
[Ir(H)2(H2)(IMes)(Qu)3]Cl (4) and [Ir(H)3(IMes)(Qu)2] (6). Both 2 
and 3 act as good SABRE catalysts with quinazoline as 
substrate whilst 5 performs the same function with 3,4–
dihydroquinazoline. All three of these complexes, when 
monitored by NMR spectroscopy, show high levels of 
hyperpolarisation in the heteroatom containing rings.  
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Scheme 2 Route for the outer–sphere conversion of quinazoline into 3,4–
dihydroquinazoline by 3 as determined by DFT. 
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